Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

What Does the Forecast Indicate for the Thrombophilia Market From 2025 to 2029?

Recent years have seen solid growth in the thrombophilia market size. It is anticipated to increase from $17.03 billion in 2024 to $18.18 billion in 2025, reflecting a compound annual growth rate (CAGR) of 6.7%. This growth during the historic period is linked with the rising awareness, research and development in anticoagulant therapies, an aging population cohort, advancements in genetic research, and an uptick in the prevalence of thrombotic disorders.

The market for thrombophilia is anticipated to experience substantial expansion in the coming years. It is projected to escalate to $24.57 billion by 2029, with a Compound Annual Growth Rate (CAGR) of 7.8%. The swelling growth during this forecast period is attributed to factors such as personalized healthcare, the introduction of new therapies, the integration of artificial intelligence, healthcare regulations and policies, and enhanced patient education and autonomy. Leading trends in the forecasted duration are progress in technology, extended deployment of telemedicine, increasing incidence rates, advancements in biopharmaceuticals, and joint research endeavors.

Download The Free Sample Report Here:

https://www.thebusinessresearchcompany.com/sample.aspx?id=9439&type=smp

What Elements Are Contributing To Growth In The Thrombophilia Market?

The thrombophilia market’s growth is predicted to be spurred by an aging population. This group, defined as individuals aged 65 and older, forms a significant proportion of the dependent population, calculated as the total sum of seniors and youngsters relative to the entire population. As thrombophilic risk factors are prevalent among the elderly, they provide a means of recognizing individuals who might have unfavorable clinical outcomes. Therefore, an increase in the aged population will elevate the market by stimulating demand for thrombophilia medication. For example, as per figures provided by America’s Health Rankings, a US health outcomes evaluator, in 2022, there are approximately 56 million adults aged 65 and up, making up about 16.9% of the entire US populace. This figure is projected to rise to over 73.1 million by 2030. Thus, the growing senior population is fueling the thrombophilia market’s expansion.

Which Segments Are Detailed In The Global Thrombophilia Market Report?

The thrombophilia market covered in this report is segmented –

1) By Type: Factor V Leiden, Prothrombin 20210, Antiphospholipid Syndrome, Other Type

2) By Drugs: Heparin, Warfarin, Other Drugs

3) By Route Of Administration: Oral, Parenteral, Other Route Of Administration

4) By End-Users: Hospitals, Homecare, Specialty Centers, Other End Users

Subsegments:

1) By Factor V Leiden: Genetic Testing, Anticoagulant Therapy

2) By Prothrombin 20210: Genetic Testing, Anticoagulant Therapy

3) By Antiphospholipid Syndrome: Antiphospholipid Antibody Testing, Anticoagulant Therapy

4) By Other Types: Protein C Deficiency, Protein S Deficiency, Antithrombin III Deficiency, Other Genetic Conditions

Which Emerging Trends And Strategic Shifts Are Shaping The Thrombophilia Market?

The thrombophilia market is seeing a surge in popularity due to technological advancements. The primary players in the market are focusing on creating innovative technologies to maintain their standing. For example, in May 2023, the University of California, San Diego’s researchers pioneered a revolutionary technology called Eloctate, which could alter the course of hemophilia treatment. This ingenious method employs a unique fusion protein increasing coagulation factors’ stability and half-life in the bloodstream. The aim is to combine this innovative technology with existing treatments to produce long-acting drugs needing less frequent dosages, thereby enhancing patient adherence and improving their life quality.

Who Are The Key Contributors To Growth In The Thrombophilia Market?

Major companies operating in the thrombophilia market include Pfizer Inc., F. Hoffmann-La Roche Limited, Changzhaou Qianhong Bio-pharma Co. Limited, Fresenius Kabi AG, Hebei Changshan Biochemical Pharmaceutical Co. Limited, Hikma Pharmaceuticals PLC., Novartis AG, Shanghai Fosun Pharmaceutical (Group) Co. Ltd., Shenzhen Hepalink Pharmaceutical Group Co. Limited, Teva Pharmaceutical Industries Limited, Yino Pharma Limited, Sanofi SA, Eisai Co. Limited, Boehringer Ingelheim GmbH, Instrumentation Laboratory SpA, Johnson & Johnson, Laurus Lab, Bristol-Myers Squibb, Roche, Abbott, C. H. Boehringer Sohn, Portola Pharmaceuticals, Daiichi Sankyo, Bayer Group, GlaxoSmithKline plc, CSL Behring

Get The Full Report Here:

https://www.thebusinessresearchcompany.com/report/thrombophilia-global-market-report

Which Region Is Projected To Lead The Thrombophilia Market By 2025?

North America was the largest region in the thrombophilia market in 2024. The regions covered in the thrombophilia market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Request For A Customized Report:

https://www.thebusinessresearchcompany.com/customise?id=9439&type=smp

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model